Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Myskin Cornea
- Development stage
- Unknown
- Lead developer
- Celltran
- Modality
- Cell Therapies
- Administration
- Ophthalmic
01
Overview
**Myskin Cornea** is a historical Celltran pipeline product reported as being intended for treatment of corneal damage. Publicly available material identifies it as a potential product in the former Celltran portfolio, but does not disclose an INN, precise cellular composition, molecular target, dosage form, route of administration, clinical-study record, regulatory approval, or current development status. ([aimmicro.com](https://www.aimmicro.com/blog/entry/york-pharma1/))
- Brand names
- Myskin Cornea
Beyond the preview
Go deeper on Myskin Cornea.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Myskin Cornea.